SAJDVD: VOLUME 3, ISSUE 1, MARCH 2006
  1. Title: Glucose monitoring : quality and cost-effectiveness : editorial
    Authors: Delport, Rhena
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.3-4
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  2. Title: Effective management of type 2 diabetes and metabolic syndrome : beyond glucose control : editorial
    Authors: Krentz, Andrew J.
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.6-7
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  3. Title: Stunted girls have greater subcutaneous fat deposits : implications for the development of type 2 diabetes mellitus in developing countries : editorial
    Authors: Kruger, H. Salome
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.9-11
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  4. Title: Cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment : review
    Authors: Wong, Nathan D.
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.12-20
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Notes: This pdf, as supplied by the publisher, is unfortunately not searchable.
    Abstract: The metabolic syndrome is a clustering of risk factors known to promote or increase the risk for development of cardiovascular disease. Approximately 25-35% of the adult population of developed countries are characterised with metabolic syndrome by different definitions. Metabolic syndrome, even in the absence of diabetes, is associated with an increased risk of cardiovascular disease and total mortality, and is related to an increased risk for the development of diabetes. Initial evaluation of coronary heart disease risk involves global risk estimation using Framingham or other algorithms for risk prediction. Given the absence of key metabolic syndrome risk factors (namely obesity, elevated triglycerides, and impaired fasting glucose) in these algorithms, elevations in these factors need to be considered in individual patient risk evaluation. Further, consideration of screening for novel risk factors such as C-reactive protein, as well as subclinical atherosclerosis (from carotid ultrasound, computed tomography, or anklebrachial index), can further refine the estimation of future cardiovascular disease risk. The presence of subclinical atherosclerosis or elevated levels of C-reactive protein can potentially modify recommended treatment goals for lipid and other cardiovascular risk factors. The American Heart Association and US National Heart Lung and Blood Institute have recently released revised guidelines for the diagnosis and clinical management of metabolic syndrome. This article examines global assessment of cardiovascular risk in persons with metabolic syndrome, the role of screening for subclinical disease in risk assessment, as well as treatment strategies and their implications for reducing cardiovascular risk in those with metabolic syndrome.
     
  5. Title: Treatment of lipids to reduce cardiovascular risk among people with the metabolic syndrome or type 2 diabetes : review
    Authors: Wild, Sarah H.; Byrne, Christopher D.
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.21-25
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: The metabolic syndrome is present in approximately 20% of general populations in developed countries and in approximately 80% of people with type 2 diabetes. High triglyceride levels, low high-density cholesterol levels and central obesity are three of the five features of the metabolic syndrome and contribute to the increased risk of cardiovascular disease (CVD) among people with the metabolic syndrome. Lifestyle interventions and treatment with statins reduce risk of CVD but absolute risk of cardiovascular events among high-risk populations remains high. This article reviews the options for treating the atherogenic dyslipidaemia associated with the metabolic syndrome.
     
  6. Title: Blood pressure reduction in the metabolic syndrome and type 2 diabetes : current concepts : review
    Authors: Schachter, Michael
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.26-29
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Notes: This pdf, as supplied by the publisher, is unfortunately not searchable.
     
  7. Title: Microalbuminuria - the next target for vascular disease prevention? : commentary
    Authors: Afzali, Behdad; Marsh, James E.
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.30-31
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  8. Title: Report on South African clinical meeting on insulin detemir. A new basal insulin analogue shows benefit in diabetes care : clinical meeting report
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.32-36
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Notes: This pdf, as supplied by the publisher, is unfortunately not searchable.
     
  9. Title: Humalog(R) Mix 50TM targets needs of type 2 diabetic patients : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.38, 40
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  10. Title: The promise of ONTARGET : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.41-42
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  11. Title: PROactive subgroup : pioglitazone reduces events in type 2 diabetic patients with previous myocardial infarction : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.43
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  12. Title: Improved early morning BP control using telmisartan in overweight patients with hypertension and type 2 diabetes : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.44
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Notes: This pdf, as supplied by the publisher, is unfortunately not searchable.
     
  13. Title: More patients benefit from using long-acting analogue - insulin detemir : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.45-46
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  14. Title: Improving the sexual quality of life in patients with diabetes and hypertension : drug trends in diabetes
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.46, 48
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
     
  15. Title: Travatan(R) eye drops now approved for first-line treatment : diabetes news
    From: South African Journal of Diabetes and Vascular Disease, Vol 3, Issue 1, Mar
    Published: 2006
    Pages: p.48
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
RELIABLE EXPERT INFORMATION
The SAJDVD’s main focus is providing new and relevant information for doctors, nurses and allied professionals involved in caring for the diabetes patient.

But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
All Rights Reserved 2016 © Clinics Cardive Publishing (Pty) Ltd.
The content on this website is intended for healthcare professionals unless stated otherwise.

Advertisements on this website do not constitute a guarantee or endorsement by the journal or publisher of the quality or value
of such products or of the claims made for it by its manufacturer.

Website Development by Design Connection.